Care announced publication by The New England Journal of Medicine of results from the company’s pivotal trial of Control-IQ+ ...

Tandem Diabetes launches Control-IQ+ technology commercially in the United States. Control-IQ+ is compatible with t:slim X2 ...

Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

Tandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, today announced publication by The New England Journal of Medicine (NEJM) of positive results from the ...

Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...

This category is aimed at recognising and honouring exporters in the manufacturing, services, and trading sectors.

With rising global temperatures due to climate change, heat stress in livestock is a growing concern. Ranier van Heerden, ...

Furthermore, it can recommend and deliver correction boluses when glucose values are predicted to exceed predefined thresholds. Supported by grants from JDRF, The Helmsley Charitable Trust ...